Showing results (241-250 of 252) with videos related to
Sort By:
Pageof 26
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Randomized phase II study evaluating oxaliplatin alone, oxaliplatin combined with infusional 5-FU, and infusional 5-FU alone in advanced pancreatic carcinoma patientsM Ducreux, E Mitry, M Ould-Kaci, et al.Nature Communications|July 28, 2022
A modular spring-loaded actuator for mechanical activation of membrane proteinsA Mills, N Aissaoui, D Maurel, et al.Nucleosides, Nucleotides & Nucleic Acids|September 21, 2001
Anti-HBV specific beta-L-2'-deoxynucleosidesM L Bryant, E G Bridges, L Placidi, et al.Antimicrobial Agents and Chemotherapy|December 20, 2000
Antiviral L-nucleosides specific for hepatitis B virus infectionM L Bryant, E G Bridges, L Placidi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1997
Concomitant chemoradiotherapy followed, where feasible, by surgery for cancer of the esophagusG Ganem, B Dubray, Y Raoul, et al.Antiviral Chemistry & Chemotherapy|October 12, 2001
Antiviral beta-L-nucleosides specific for hepatitis B virus infectionD N Standring, E G Bridges, L Placidi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2000
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancerA de Gramont, A Figer, M Seymour, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 15, 2023
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal CancerA de Gramont, A Figer, M Seymour, et al.European Journal of Cancer (Oxford, England : 1990)|April 7, 2018
5-year overall survival after early breast cancer diagnosed during pregnancy: A retrospective case-control multicentre French studyA Ploquin, B Pistilli, E Tresch, et al.South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|October 11, 2022
Prophylaxis is the new standard of care in patients with haemophiliaJ Mahlangu, F Bassa, M Bassingthwaighte, et al.Pageof 26